Relmada Therapeutics (RLMD) Stock Chart & Stock Price History $0.68 -0.02 (-3.06%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$0.68 0.00 (-0.22%) As of 06/20/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Relmada Therapeutics Stock Price Performance The Relmada Therapeutics (RLMD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 77.61%, with a year-to-date return of 30.48%. In the past month, the stock has increased 10.33%, reflecting recent market activity. As of the latest close, Relmada Therapeutics traded at $0.68 with a market cap of $22.52 million and volume of 349,029 shares. Five years ago, the stock traded at $47.76, representing a 98.58% decrease over that period. At the time, it had a market cap of $725.86 million and a volume of 482,400 shares. Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.62%1 Month Performance+10.33%3 Month Performance+128.99%Year-To-Date Performance+30.48%1 Year Performance-77.61%5 Year Performance-98.58% RLMD Stock Chart for Sunday, June, 22, 2025 RLMD Chart by TradingView Relmada Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/20/2025$0.70$0.68-3.06%$0.72$0.68349,029 shs$22.52 million06/19/2025$0.70$0.70$0.72$0.67212,290 shs$23.23 million06/18/2025$0.70$0.70-0.58%$0.72$0.67212,290 shs$23.23 million06/17/2025$0.71$0.70-0.58%$0.74$0.68171,274 shs$23.37 million06/16/2025$0.70$0.71+1.13%$0.76$0.66253,376 shs$23.50 million06/13/2025$0.71$0.70-0.85%$0.74$0.67196,785 shs$23.24 million06/12/2025$0.77$0.71-7.87%$0.79$0.69723,296 shs$23.44 million06/11/2025$0.79$0.77-3.24%$0.81$0.75228,174 shs$25.44 million06/10/2025$0.83$0.79-4.15%$0.82$0.75469,594 shs$26.30 million06/09/2025$0.83$0.83-1.01%$0.87$0.79275,987 shs$27.43 million Get the Latest News and Ratings for RLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/06/2025$0.82$0.83+1.82%$0.90$0.79474,369 shs$27.71 million06/05/2025$0.74$0.82+11.13%$0.87$0.701.21 million shs$27.22 million06/04/2025$0.70$0.74+5.82%$0.75$0.65307,241 shs$24.49 million06/03/2025$0.71$0.70-1.58%$0.71$0.68221,283 shs$23.15 million06/02/2025$0.72$0.71-1.65%$0.73$0.66415,004 shs$23.52 million05/30/2025$0.72$0.72-0.18%$0.77$0.69586,313 shs$23.91 million05/29/2025$0.72$0.72-0.44%$0.75$0.68615,138 shs$23.96 million05/28/2025$0.66$0.72+9.50%$0.74$0.651.17 million shs$24.06 million05/27/2025$0.64$0.66+3.53%$0.70$0.62676,351 shs$21.97 million05/26/2025$0.64$0.64$0.66$0.58742,653 shs$21.22 million05/23/2025$0.62$0.64+3.97%$0.66$0.58742,653 shs$21.22 million05/22/2025$0.52$0.62+18.43%$0.64$0.491.05 million shs$20.41 million05/21/2025$0.60$0.52-13.02%$0.66$0.492.16 million shs$17.24 million Related Companies Anixa Biosciences Stock Price Chart Unicycive Therapeutics Stock Price Chart Zentalis Pharmaceuticals Stock Price Chart Procaps Group Stock Price Chart Cassava Sciences Stock Price Chart MacroGenics Stock Price Chart HilleVax Stock Price Chart Genelux Stock Price Chart IO Biotech Stock Price Chart TScan Therapeutics Stock Price Chart Receive RLMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RLMD) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relmada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RLMD Stock Free RLMD Stock Alerts